No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

Table 5 Association of HIV status and DM2 status with soluble markers

	ln (Adiponectin)			ln (IL-6)			ln (TNF- α)			ln (sCD14)
	Unadjusted Β-coefficient (95% CI)	Adjusted Β-coefficient (95%CI)	Unadjusted p-interaction	Unadjusted Β-coefficient (95% CI)	Adjusted Β-coefficient (95%CI)	Unadjusted p-interaction	Unadjusted Β-coefficient (95% CI)	Adjusted Β-coefficient (95%CI)	Unadjusted p-interaction	Unadjusted Β-coefficient (95% CI)	Adjusted Β-coefficient (95%CI)	Unadjusted p-interaction
HIV status	−0.03 (− 0.24;0.18)	0.04 (− 0.16;0.24)	0.180	0.08 (− 0.28;0.45)	0.06 (− 0.32;0.44)	0.886	0.13 (− 0.07;0.32)	0.19 (0.04;0.35)	0.720	0.46 (0.26;0.65)	0.44 (0.22;0.66)	0.835
DM2 status	− 0.45 (− 0.64;-0.27)	− 047 (− 0.69;-0.26)	0.180	0.51 (0.16;0.85)	0.51 (0.09;0.92)	0.886	0.21 (0.02;0.40)	0.09 (− 0.08;0.26)	0.720	0.07 (− 0.15; 0.29)	0.08 (− 0.15;0.31)	0.835

Multivariable models have been adjusted for age, sex and BMI. Abbreviations: IL-6 Interleukin-6, TNF- α Tumor necrosis factor-alfa, sCD14 Soluble CD14, DM2 Diabetes mellitus type 2

ISSN: 1471-2334